Novartis employs a variety of ACD/Labs software in support of structure elucidation and structure verification in pharmaceutical development and post-commercialization. Here they present:
- Their workflow for structure identification and elucidation for impurities and degradants
- Time-savings from automated structure verification—a system supporting research chemists for several years
- The importance of integrated, centralized data management in impurity identification, forced degradation studies, and stability studies